• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人细胞因子在免疫缺陷小鼠中的转基因表达并不能促进BCR-ABL1转导的人脐带血细胞的髓系扩增。

Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.

作者信息

Askmyr Maria, von Palffy Sofia, Hansen Nils, Landberg Niklas, Högberg Carl, Rissler Marianne, Ågerstam Helena, Fioretos Thoas

机构信息

Department of Clinical Genetics, Lund University, Lund, Sweden.

Department of Clinical Genetics, University and Regional Laboratories, Region Skåne, Lund, Sweden.

出版信息

PLoS One. 2017 Oct 12;12(10):e0186035. doi: 10.1371/journal.pone.0186035. eCollection 2017.

DOI:10.1371/journal.pone.0186035
PMID:29023488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5638313/
Abstract

Several attempts have been made to model chronic myeloid leukemia (CML) in a xenograft setting but expansion of human myeloid cells in immunodeficient mice has proven difficult to achieve. Lack of cross-reacting cytokines in the microenvironment of the mice has been proposed as a potential reason. In this study we have used NOD/SCID IL2-receptor gamma deficient mice expressing human SCF, IL-3 and GM-CSF (NSGS mice), that should be superior in supporting human, and particularly, myeloid cell engraftment, to expand BCR-ABL1 expressing human cells in order to model CML. NSGS mice transplanted with BCR-ABL1 expressing cells became anemic and had to be sacrificed due to illness, however, this was not accompanied by an expansion of human myeloid cells but rather we observed a massive expansion of human T-cells and macrophages/histiocytes. Importantly, control human cells without BCR-ABL1 expression elicited a similar reaction, although with a slight delay of disease induction, suggesting that while BCR-ABL1 contributes to the inflammatory reaction, the presence of normal human hematopoietic cells is detrimental for NSGS mice.

摘要

已经进行了几次尝试在异种移植环境中模拟慢性粒细胞白血病(CML),但事实证明在免疫缺陷小鼠中扩增人髓细胞很难实现。小鼠微环境中缺乏交叉反应性细胞因子被认为是一个潜在原因。在本研究中,我们使用了表达人干细胞因子(SCF)、白细胞介素-3(IL-3)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)的NOD/SCID白细胞介素-2受体γ缺陷小鼠(NSGS小鼠),其在支持人细胞尤其是髓细胞植入方面应该更具优势,以扩增表达BCR-ABL1的人细胞来模拟CML。移植了表达BCR-ABL1细胞的NSGS小鼠出现贫血,并且由于疾病不得不被处死,然而,这并未伴随人髓细胞的扩增,相反,我们观察到了人T细胞和巨噬细胞/组织细胞的大量扩增。重要的是,没有BCR-ABL1表达的对照人细胞引发了类似的反应,尽管疾病诱导稍有延迟,这表明虽然BCR-ABL1促成了炎症反应,但正常人造血细胞的存在对NSGS小鼠是有害的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d536/5638313/af649a7485d8/pone.0186035.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d536/5638313/a9f089b13af1/pone.0186035.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d536/5638313/39c2bd11066a/pone.0186035.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d536/5638313/af649a7485d8/pone.0186035.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d536/5638313/a9f089b13af1/pone.0186035.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d536/5638313/39c2bd11066a/pone.0186035.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d536/5638313/af649a7485d8/pone.0186035.g003.jpg

相似文献

1
Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.人细胞因子在免疫缺陷小鼠中的转基因表达并不能促进BCR-ABL1转导的人脐带血细胞的髓系扩增。
PLoS One. 2017 Oct 12;12(10):e0186035. doi: 10.1371/journal.pone.0186035. eCollection 2017.
2
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.在小鼠中,通过BCR/ABL诱导慢性髓性白血病样骨髓增殖性疾病并不需要白细胞介素3和粒细胞-巨噬细胞集落刺激因子。
Blood. 2001 Mar 1;97(5):1442-50. doi: 10.1182/blood.v97.5.1442.
3
Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.在免疫缺陷小鼠中模拟慢性髓性白血病揭示了异常肥大细胞的扩增和前B细胞的积累。
Blood Cancer J. 2014 Dec 12;4(12):e269. doi: 10.1038/bcj.2014.89.
4
Improved multilineage human hematopoietic reconstitution and function in NSGS mice.提高 NSGS 小鼠的多谱系人类造血重建和功能。
PLoS One. 2018 Dec 12;13(12):e0209034. doi: 10.1371/journal.pone.0209034. eCollection 2018.
5
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.原发性慢性髓性白血病干细胞的不同亚群植入免疫缺陷小鼠体内,并产生人类疾病模型。
Leukemia. 2005 Mar;19(3):435-41. doi: 10.1038/sj.leu.2403649.
6
Models of chronic myeloid leukemia.慢性髓性白血病模型
Curr Oncol Rep. 2001 May;3(3):228-37. doi: 10.1007/s11912-001-0055-y.
7
BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice.BCR-ABL转导的人脐血细胞在免疫缺陷小鼠中产生异常细胞群体。
Leukemia. 2005 Mar;19(3):442-8. doi: 10.1038/sj.leu.2403650.
8
Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.SPA-1在小鼠模型中由表达BCR-ABL的造血祖细胞诱导的慢性粒细胞白血病表型中的作用。
Cancer Res. 2006 Oct 15;66(20):9967-76. doi: 10.1158/0008-5472.CAN-06-1346.
9
Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.BCR-ABL反义寡脱氧核苷酸对慢性髓性白血病细胞生长的基因靶向特异性抑制作用。
Folia Histochem Cytobiol. 1991;29(3):85-9.
10
Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia.抑制异戊烯基半胱氨酸羧甲基转移酶可增强慢性髓性白血病中BCR-ABL1酪氨酸激酶抑制诱导的细胞凋亡。
Exp Hematol. 2016 Mar;44(3):189-93.e2. doi: 10.1016/j.exphem.2015.12.002. Epub 2015 Dec 17.

引用本文的文献

1
Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.接受人源 CD34+造血干细胞或患者来源白血病异种移植的 NSG-SGM3 小鼠中肥大细胞和嗜酸性粒细胞增生以及 HLH/MAS 样疾病的发展。
Vet Pathol. 2021 Jan;58(1):181-204. doi: 10.1177/0300985820970144. Epub 2020 Nov 19.
2
Cancer Immunotherapies and Humanized Mouse Drug Testing Platforms.癌症免疫疗法与人性化小鼠药物测试平台。
Transl Oncol. 2019 Jul;12(7):987-995. doi: 10.1016/j.tranon.2019.04.020. Epub 2019 May 20.

本文引用的文献

1
A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.一种可用于抗 CD33 和抗 IL-6R 治疗的巨噬细胞活化综合征异种移植模型。
JCI Insight. 2016 Sep 22;1(15):e88181. doi: 10.1172/jci.insight.88181.
2
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models.IL1RAP 抗体阻断 IL-1 诱导的候选 CML 干细胞扩增,并在异种移植模型中介导细胞杀伤。
Blood. 2016 Dec 8;128(23):2683-2693. doi: 10.1182/blood-2015-11-679985. Epub 2016 Sep 12.
3
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
人端粒酶逆转录酶(hTERT)使人类急性早幼粒细胞白血病(AE)前体细胞永生化,从而导致白血病转化。
Oncotarget. 2016 Aug 30;7(35):55939-55950. doi: 10.18632/oncotarget.11093.
4
Establishing a murine xenograft-model for long-term analysis of factors inducing chromosomal instability in myelodysplastic syndrome: Pitfalls and successes.建立用于长期分析骨髓增生异常综合征中诱导染色体不稳定因素的小鼠异种移植模型:陷阱与成功经验
Cancer Genet. 2016 Jun;209(6):258-66. doi: 10.1016/j.cancergen.2016.04.004. Epub 2016 Apr 22.
5
Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model.在基于人骨髓样支架的异种移植模型中模拟 BCR-ABL 和 MLL-AF9 白血病。
Leukemia. 2016 Oct;30(10):2064-2073. doi: 10.1038/leu.2016.108. Epub 2016 Apr 29.
6
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.靶向人白细胞介素1受体辅助蛋白(IL1R3)的抗体在急性髓系白血病异种移植模型中显示出治疗效果。
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10786-91. doi: 10.1073/pnas.1422749112. Epub 2015 Aug 10.
7
Xenograft models for normal and malignant stem cells.异体移植模型用于正常和恶性干细胞。
Blood. 2015 Apr 23;125(17):2630-40. doi: 10.1182/blood-2014-11-570218. Epub 2015 Mar 11.
8
Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.在免疫缺陷小鼠中模拟慢性髓性白血病揭示了异常肥大细胞的扩增和前B细胞的积累。
Blood Cancer J. 2014 Dec 12;4(12):e269. doi: 10.1038/bcj.2014.89.
9
Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.显性负性 Ikaros 与 BCR-ABL1 协同诱导异种移植中的人急性髓系白血病。
Leukemia. 2015 Jan;29(1):177-87. doi: 10.1038/leu.2014.150. Epub 2014 May 5.
10
OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.OKT3 可预防异种移植物抗宿主病,并可允许从未分选人源造血组织中可靠地起始异种移植物。
Blood. 2014 Jun 12;123(24):e134-44. doi: 10.1182/blood-2014-02-556340. Epub 2014 Apr 28.